$OPXA News Opexa, BreitBurn, Hudson Pacific price

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$OPXA News

Opexa, BreitBurn, Hudson Pacific price offerings 1:07 p.m. Feb. 7, 2013 - MarketWatch.com
Opexa Therapeutics grants drug license to Merck 10:38 a.m. Feb. 5, 2013 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 5:27 p.m. Jan. 5, 2011 - MarketWatch
Glaxo, Opexa in drug sector spotlight 1:15 p.m. Jan. 5, 2011 - Val Brickates Kennedy
Opexa soars on talks with FDA over MS drug 11:56 a.m. Jan. 5, 2011 - William Spain
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy

Opexa Is Personalizing The Treatment Of Autoimmune Disease 9:24 a.m. June 3, 2014 - Seeking Alpha
Think Like A Brain Surgeon: Dr. Christopher James Offers Fresh Perspectives On 6 Exciting Biotechs 3:29 a.m. May 16, 2014 - Seeking Alpha
10-Q: OPEXA THERAPEUTICS, INC. 4:09 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Opexa Therapeutics: An Optimal Buyout Candidate Pending Successful Topline Results From Abili-T 9:00 a.m. April 30, 2014 - Seeking Alpha
OXiGENE Incorporated: An Undervalued Opportunity In Biopharmaceuticals 1:35 p.m. March 25, 2014 - Seeking Alpha
Opexa Therapeutics: A Long-Term Perspective For Price Appreciation 12:04 p.m. March 10, 2014 - Seeking Alpha
Will Opexa Become A Multi Bagger? 1:19 p.m. Feb. 21, 2014 - Seeking Alpha
Weekly CFO Buys Highlight 12:32 p.m. Aug. 19, 2013 - GuruFocus.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 12:44 p.m. Aug. 15, 2013 - Seeking Alpha
The Highs And The Lows: Opexa's Changing Market Trends 2:49 p.m. Aug. 12, 2013 - Seeking Alpha
Closing Bell for Thursday on Wall Street: Markets Open Lower, Close with Gains 3:30 p.m. Aug. 8, 2013 - 247WallSt.com
Opexa Morphs from Mystery Mega-Rally to Money Killer 9:56 a.m. Aug. 8, 2013 - 247WallSt.com
Closing Bell for Wednesday on Wall Street: Markets Lower at Open, Lower at Close 3:36 p.m. Aug. 7, 2013 - 247WallSt.com
Biotech Movers: Optimer Rockets, Ziopharm in Free Fall 3:25 a.m. April 8, 2013 - InvestorPlace.com
Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here 9:02 p.m. March 26, 2013 - Seeking Alpha
Market Close: Big Winners & Losers for March 26, 2013 (LEDS, BVX, PTEK, OPXA, LOGM, ZIOP, STXS, GMAN, GMXR, PRTS) 3:35 p.m. March 26, 2013 - 247WallSt.com
Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors 9:01 a.m. March 26, 2013 - Seeking Alpha
Opexa Therapeutics Poised For Breakout 10:39 a.m. March 12, 2013 - Seeking Alpha
Market Close: Today’s Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC) 4:56 p.m. March 6, 2013 - 247WallSt.com
Opexa Therapeutics Gets Attention From Institutions, Should It Get Yours? 3:22 p.m. Feb. 14, 2013 - Seeking Alpha


Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Second Quarter 2014 Financial Results 9:01 a.m. Aug. 11, 2014 - BusinessWire - BZX
RedChip Issues Research Profile on Opexa Therapeutics 10:59 a.m. July 17, 2014 - GlobeNewswire
RedChip's July 16-17 Global Online CEO Conference Presentation Schedule Now Available 11:31 a.m. July 8, 2014 - GlobeNewswire
Opexa Therapeutics Joins Russell Microcap Index 8:01 a.m. June 30, 2014 - BusinessWire - BZX
Top Gainers Technical Data -- Research on SolarCity, Clean Energy Fuel, Opexa Therapeutics, and Atossa Genetics 7:50 a.m. May 30, 2014 - PR Newswire - PRF
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg 8:38 a.m. May 29, 2014 - GlobeNewswire
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis 8:02 a.m. May 13, 2014 - BusinessWire - BZX
Opexa Therapeutics Announces News Release and Conference Call to Discuss First Quarter 2014 Financial Results 8:02 a.m. May 12, 2014 - BusinessWire - BZX
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020 12:33 p.m. April 23, 2014 - PR Newswire - PRF
Opexa Therapeutics to Attend the American Academy of Neurology Annual Meeting 8:01 a.m. April 22, 2014 - BusinessWire - BZX
RedChip Global Online CEO Conference, April 23-24, Featuring Presentations From 30+ Small-Cap Companies 10:24 a.m. April 21, 2014 - GlobeNewswire
RedChip TV Announces Lineup for This Week's Show on Fox Business and Bloomberg 10:19 a.m. April 10, 2014 - GlobeNewswire
Lawsuits, Clinical Studies, Financial Results, and Stock Movements - Analyst Notes on Idenix, BG Medicine, Progenics, Omeros, and Opexa 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Opexa Therapeutics Appoints Prof. Hans-Peter Hartung and Timothy Barabe to the Board of Directors 8:02 a.m. March 20, 2014 - BusinessWire - BZX
Opexa Therapeutics Reports Year End 2013 Financial Results and Provides Corporate Update 5:20 p.m. Feb. 27, 2014 - BusinessWire - BZX
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Year End 2013 Financial Results 9:02 a.m. Feb. 26, 2014 - BusinessWire - BZX
DELiA*s Path to Recovery Hampered By Sluggish Retail Marketplace 11:04 a.m. Feb. 24, 2014 - ACCESSWIRE
Opexa Therapeutics CEO to Present at the 2014 Leerink Global Healthcare Conference 3:17 p.m. Feb. 11, 2014 - BusinessWire - BZX
Opexa Therapeutics to Present at the 16th Annual BIO CEO & Investor Conference 10:00 a.m. Jan. 29, 2014 - BusinessWire - BZX
Opexa Therapeutics Chief Scientific Officer Invited as Guest Speaker at the Phacilitate Cell & Gene Therapy Forum 10:01 a.m. Jan. 23, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 3

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 2

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 2

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 6

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 5

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackRock's Strong Performance Lifts Market Spirits

Updated Category News Views 62

BlackRock's Earnings Impact Future Market Trends As investors eagerly glance at the market, recent trends suggest a positive shift, particularly with BlackRock, Inc. reporting remarkable third-quarter earnings. The upbeat results have lifted not only the company’s profile but also the sentiments across various sectors. Market Overview In recent trading sessions, U.S....

Continue Reading
Endo Unveils I Got Somebody Campaign for Peyronie's Disease

Updated Category News Views 648

Endo Launches Awareness Campaign for Peyronie’s Disease Endo, Inc. (OTCQX: NDOI) has recently introduced a compelling initiative titled I Got Somebody. This campaign is designed to encourage men to confront their feelings of embarrassment around Peyronie's disease (PD) and to have open discussions about this condition which affects many. The company aims to empower men...

Continue Reading
Investigation Launched into Aehr Test Systems for Investors' Losses

Updated Category News Views 218

Investigation into Aehr Test Systems, Inc. Focused on Investor Protection The Law Offices of Frank R. Cruz are actively investigating Aehr Test Systems, Inc. (NASDAQ: AEHR) in light of significant concerns raised regarding the company’s adherence to federal securities laws. This investigation comes as a response to alarming financial disclosures made public by the...

Continue Reading
SeaStar Medical Advances adult AKI Treatment with Stanford

Updated Category News Views 69

SeaStar Medical Welcomes Stanford Medicine's Enrollment in AKI Trial SeaStar Medical Holding Corporation (NASDAQ: ICU) is excited to announce that Stanford Medicine will begin actively enrolling subjects in its pivotal trial focused on Adult Acute Kidney Injury (AKI). This collaboration emphasizes the company’s mission to enhance treatment options for patients...

Continue Reading
Exciting Updates on Class A Shares for Investors and Stakeholders

Updated Category News Views 163

Important Distribution Announcement for Class A Shareholders In a recent announcement, Real Estate Split Corp. (TSX: RS) has excitedly shared plans to distribute dividends to Class A shareholders. This distribution not only signifies growth but also represents the company's commitment to providing value to its investors. Key Dates for the Upcoming Distribution For...

Continue Reading